Home › Trial NCT04666649
Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)
- Trial IDNCT04666649
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorUniversity of Maryland, Baltimore
- Enrollment27
- Start date2021-03-10
- ConditionsRelapsed or Refractory Acute Myeloid Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.